A genomic analysis of over 200 mesothelioma tumors uncovers previously unknown mutations – some of which arise in other cancers and may be treatable with existing drugs.
A genomic analysis of over 200 mesothelioma tumors uncovers previously unknown mutations – some of which arise in other cancers and may be treatable with existing drugs.